Genprex, Inc. announced on April 21, 2026, a new Sponsored Research Agreement with UT MD Anderson to study biomarkers for its Reqorsa® Gene Therapy aimed at lung cancer treatment. This agreement signifies ongoing collaboration after previous successful partnerships and supports patient selection strategies in ongoing clinical trials.